ZA845670B - Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer - Google Patents

Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer

Info

Publication number
ZA845670B
ZA845670B ZA845670A ZA845670A ZA845670B ZA 845670 B ZA845670 B ZA 845670B ZA 845670 A ZA845670 A ZA 845670A ZA 845670 A ZA845670 A ZA 845670A ZA 845670 B ZA845670 B ZA 845670B
Authority
ZA
South Africa
Prior art keywords
cancer
treatment
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA845670A
Other languages
English (en)
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ZA845670B publication Critical patent/ZA845670B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA845670A 1983-07-29 1984-07-23 Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer ZA845670B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8348791A IT1212882B (it) 1983-07-29 1983-07-29 Derivati basici della cumarina

Publications (1)

Publication Number Publication Date
ZA845670B true ZA845670B (en) 1985-03-27

Family

ID=11268572

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA845670A ZA845670B (en) 1983-07-29 1984-07-23 Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer

Country Status (25)

Country Link
US (1) US4737517A (zh)
EP (1) EP0133766B1 (zh)
JP (1) JPS6054378A (zh)
KR (1) KR870001483B1 (zh)
AR (2) AR240816A1 (zh)
AT (1) ATE60329T1 (zh)
AU (1) AU581853B2 (zh)
BE (1) BE900225A (zh)
CH (1) CH662563A5 (zh)
DE (1) DE3483989D1 (zh)
DK (1) DK354784A (zh)
ES (4) ES534581A0 (zh)
FI (1) FI85269C (zh)
FR (1) FR2549832B1 (zh)
GR (1) GR82014B (zh)
HU (2) HUT36815A (zh)
IL (1) IL72515A (zh)
IN (1) IN161176B (zh)
IT (1) IT1212882B (zh)
LU (1) LU85476A1 (zh)
MX (1) MX162759A (zh)
NO (1) NO843042L (zh)
NZ (1) NZ209003A (zh)
PT (1) PT78986B (zh)
ZA (1) ZA845670B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008529A2 (en) * 1989-01-23 1990-08-09 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5516629A (en) * 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US5484951A (en) * 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
US5877185A (en) * 1991-10-22 1999-03-02 Octamer, Inc. Synergistic compositions useful as anti-tumor agents
US5482975A (en) * 1991-10-22 1996-01-09 Octamer, Inc. Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
US5783599A (en) * 1993-02-24 1998-07-21 Octamer Inc Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones
EP0645382B1 (en) * 1993-04-13 2000-07-12 Morinaga Milk Industry Co., Ltd. Coumarin derivative and use thereof
DE10352535A1 (de) * 2003-11-07 2005-06-16 Steag Microparts Gmbh Mikrostrukturierte Trennvorrichtung und Verfahren zum Abtrennen von flüssigen Bestandteilen aus einer Partikel enthaltenden Flüssigkeit
US7456214B2 (en) * 2004-05-03 2008-11-25 Baylor University Chromene-containing compounds with anti-tubulin and vascular targeting activity
US20050245489A1 (en) * 2004-05-03 2005-11-03 Pinney Kevin G Chromene-containing compounds with anti-tubulin and vascular targeting activity
BRPI0404130A (pt) * 2004-09-20 2006-05-02 Univ Rio De Janeiro cumarinas substituìdas, processo de produção de tais cumarinas e composições contendo as mesmas
CN104529972B (zh) * 2014-10-10 2016-05-18 北京工业大学 蛋白激酶抑制剂香豆素及其制备方法和医药应用
KR102053748B1 (ko) 2017-12-20 2019-12-09 강원대학교산학협력단 쿠마린 유도체를 포함하는 알레르기성 염증성 질환의 예방 또는 치료용 약학 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515721A (en) * 1967-06-26 1970-06-02 Cassella Farbwerke Mainkur Ag 3-tertiary-aminoethyl-4-methyl or phenyl-7-ethoxycarbonylmethoxy - halo or mononitro coumarins and congeners
BE761985A (fr) * 1970-10-19 1971-07-01 Recordati Chem Pharm Procede de preparation de n-alcoyl-dimethylamines
US3880885A (en) * 1971-11-23 1975-04-29 Sandoz Ag Tertiary aminoethyl isochromans and isocoumarins
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
IT1160366B (it) * 1978-12-19 1987-03-11 F I D I A Spa Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossi cumarina cloridrato preparato allo stato puro con procedimento selettivo con particolare riguardo alla sua attivita' anti-aggregante piastrinica
US4321270A (en) * 1981-01-29 1982-03-23 E. R. Squibb & Sons, Inc. Substituted chromans
CA1205028A (en) * 1981-07-01 1986-05-27 Jerald C. Hinshaw Fluorescent chelates and labeled specific binding reagents prepared therefrom

Also Published As

Publication number Publication date
AU581853B2 (en) 1989-03-09
NO843042L (no) 1985-01-30
ATE60329T1 (de) 1991-02-15
IL72515A (en) 1992-05-25
FI842997A0 (fi) 1984-07-27
FR2549832B1 (fr) 1987-08-14
AR240926A2 (es) 1991-03-27
JPS6054378A (ja) 1985-03-28
FR2549832A1 (fr) 1985-02-01
IL72515A0 (en) 1984-11-30
DK354784D0 (da) 1984-07-19
FI85269B (fi) 1991-12-13
ES545238A0 (es) 1986-11-16
ES545239A0 (es) 1986-07-16
HUT36815A (en) 1985-10-28
KR850001189A (ko) 1985-03-16
US4737517A (en) 1988-04-12
MX162759A (es) 1991-06-25
IN161176B (zh) 1987-10-10
AR240816A2 (es) 1991-02-28
BE900225A (fr) 1985-01-28
IT8348791A0 (it) 1983-07-29
ES8700246A1 (es) 1986-11-16
ES545240A0 (es) 1987-06-01
EP0133766A3 (en) 1985-12-27
KR870001483B1 (ko) 1987-08-13
EP0133766B1 (en) 1991-01-23
IT1212882B (it) 1989-11-30
HU199819B (en) 1990-03-28
EP0133766A2 (en) 1985-03-06
FI842997A (fi) 1985-01-31
ES8706139A1 (es) 1987-06-01
ES8602739A1 (es) 1985-12-16
AR240926A1 (es) 1991-03-27
CH662563A5 (fr) 1987-10-15
LU85476A1 (fr) 1984-12-06
DK354784A (da) 1985-01-30
PT78986B (en) 1986-06-18
AU3127484A (en) 1985-01-31
DE3483989D1 (de) 1991-02-28
AR240816A1 (es) 1991-02-28
NZ209003A (en) 1988-04-29
PT78986A (pt) 1985-02-20
ES8608503A1 (es) 1986-07-16
JPH0475911B2 (zh) 1992-12-02
ES534581A0 (es) 1985-12-16
FI85269C (fi) 1992-03-25
GR82014B (zh) 1984-12-12

Similar Documents

Publication Publication Date Title
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
EP0172721A3 (en) Use of phlorizin or its derivatives in the treatment of cancer
PH22022A (en) Pyrimidine derivatives, pharmaceutical composition containing same and use thereof
IL73008A0 (en) Azole derivatives,their preparation and pharmaceutical compositions containing them
ZA845670B (en) Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer
IL84765A0 (en) Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL72562A0 (en) Quinazoline derivatives and pharmaceutical compositions containing them
ZA796882B (en) Use of glycerylphosphoryl derivatives in the therapy of dislipaemia,hepatitis and like pathological conditions and pharmaceutical compositions therefor
IL71711A0 (en) Pyrimidone derivatives,their manufacture and pharmaceutical compositions containing them
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
IL68619A0 (en) Quinazoline derivatives,their manufacture and pharmaceutical compositions containing them
IL69845A (en) Tetrahydropyran-3 or 4-yl-3-amino-propoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
IL70189A (en) 2-piperazinyl-quinazoline derivatives,their proeuction and pharmaceutical compositions containing them
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH22848A (en) 3,3-dialkyl- and 3,3,-alkylene-indoline derivatives, pharmaceutical compositions comprising them and their use
PH22226A (en) Human endogenous cancer regulatory factor, process for preparing the same and pharmaceutical composition containing the same
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
IL90958A0 (en) Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them